ACAN
Americann Inc
Price:  
0.00 
USD
Volume:  
1,400.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ACAN EV/EBITDA

-365187.2%
Upside

As of 2025-07-04, the EV/EBITDA ratio of Americann Inc (ACAN) is -7.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACAN's latest enterprise value is 4.95 mil USD. ACAN's TTM EBITDA according to its financial statements is -0.64 mil USD. Dividing these 2 quantities gives us the above ACAN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.1x - 7.3x 6.2x
Forward P/E multiples 5.1x - 7.3x 6.2x
Fair Price (0.34) - (0.39) (0.37)
Upside -335379.0% - -394995.5% -365187.2%
0.00 USD
Stock Price
(0.37) USD
Fair Price

ACAN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-14 -8.34
2025-04-11 -8.42
2025-04-10 -8.37
2025-04-09 -8.54
2025-04-08 -8.30
2025-04-07 -8.54
2025-04-04 -8.46
2025-04-03 -8.53
2025-04-02 -8.82
2025-04-01 -9.07
2025-03-31 -9.00
2025-03-28 -9.94
2025-03-27 -10.44
2025-03-25 -9.28
2025-03-24 -8.96
2025-03-21 -9.01
2025-03-20 -9.35
2025-03-18 -8.96
2025-03-17 -9.10
2025-03-14 -8.95
2025-03-13 -8.95
2025-03-12 -9.19
2025-03-11 -10.25
2025-03-10 -10.20
2025-03-07 -10.20
2025-03-06 -9.29
2025-03-05 -8.91
2025-03-04 -8.93
2025-03-03 -9.01
2025-02-27 -9.12
2025-02-26 -9.17
2025-02-25 -9.17
2025-02-24 -9.33
2025-02-21 -9.19
2025-02-20 -8.82
2025-02-19 -8.88
2025-02-18 -9.10
2025-02-14 -9.02
2025-02-13 -9.14
2025-02-12 -8.76
2025-02-11 -8.83
2025-02-10 -8.72
2025-02-06 -8.93
2025-02-05 -8.61
2025-02-04 -8.57
2025-02-03 -9.08
2025-01-31 -8.56
2025-01-30 -8.56
2025-01-29 -8.80
2025-01-28 -8.80